Emcure Pharmaceuticals

Emcure Pharmaceuticals headquartered at Pune in West India is a vertically integrated Indian pharmaceutical company. The company's products include Tablets, Capsules ( both Softgel capsules and hard-gel capsules), and injectables. Emcure has proven capabilities to research, develop and supply finished formulations to the most demanding needs of the global regulated markets.

Indian plants

 * Solid Dosage facility at Hinjwadi - In 2006, Emcure received US FDA approval for its solid dosages facility at Hinjwadi, Pune. The plant manufactures solid oral formulations for the international regulated markets. With this approval, the facility has accreditation from US FDA, UK MHRA, WHO Geneva and MCC South Africa


 * Small volume parenterals facility at Hinjwadi  - USFDA and UK MHRA approved. Has lyophilization and pfs capability


 *  Onco injectable facility at Hinjwadi


 *  Solid Orals facilities at Jammu and Bhosari


 *  API manufacturing facility at Kurkumbh - USFDA approved


 * Biotech facility at Hinjwadi

US plant
USA - The company has a manufacturing facility and R&D centre at East Brunswick, New Jersey, USA.

Capital markets
Emcure is planning to raise money through an initial public offering

AIDS Initiative
Emcure voices its concerns on HIV/AIDS through its "Let's fight AIDS together" initiative and supplies Antiretroviral drugs to Africa, Asia Pacific and CIS. As a part of its corporate social responsibility it supports 'Taal', a pharmacy for HIV/AIDS patients run by HIV/AIDS patients.

Emcure has license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs.

Group Companies

 * Emcure USA http://www.emcureusa.com/
 * Gennova http://www.emcure.co.in/group_Gennova.asp
 * Zuventus http://www.zuventus.co.in:8080/jsp/default.jsp